{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:56:20Z","timestamp":1791867380454,"version":"4.3.4"},"reference-count":143,"publisher":"Impact Journals, LLC","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2106,7,5]]},"DOI":"10.18632\/oncotarget.7977","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T19:55:17Z","timestamp":1457726117000},"page":"42683-42697","source":"Crossref","is-referenced-by-count":82,"title":["MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia"],"prefix":"10.18632","volume":"7","author":[{"given":"Chiranjib","family":"Chakraborty","sequence":"first","affiliation":[{"name":"Institute for Skeletal Aging & Orthopedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon, 200704, Korea"},{"name":"Department of Bio-informatics, School of Computer and Information sciences, Galgotias University, Greater Noida, Uttar Pradesh, 203201, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Ranjan","family":"Sharma","sequence":"additional","affiliation":[{"name":"Institute for Skeletal Aging & Orthopedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon, 200704, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidhan Chandra","family":"Patra","sequence":"additional","affiliation":[{"name":"Aquaculture Research Unit, Department of Zoology, Vidyasagar University, Midnapore, West Bengal, 721102, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manojit","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Institute for Skeletal Aging & Orthopedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon, 200704, Korea"},{"name":"Aquaculture Research Unit, Department of Zoology, Vidyasagar University, Midnapore, West Bengal, 721102, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Sharma","sequence":"additional","affiliation":[{"name":"Institute for Skeletal Aging & Orthopedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon, 200704, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Soo","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute for Skeletal Aging & Orthopedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon, 200704, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Kolch","year":"2007","journal-title":"Oncogene"},{"key":"2","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.3390\/ijms14034854","article-title":"Mitogen-Activated Protein (MAP) Kinase Scaffolding Proteins: A Recount","volume":"14","author":"Tikkanen","year":"2013","journal-title":"Int J Mol Sci"},{"key":"3","first-page":"153","article-title":"Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions 1","volume":"22","author":"Cobb","year":"2001","journal-title":"Endocrine reviews"},{"key":"4","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1128\/MMBR.62.4.1264-1300.1998","article-title":"MAP kinase pathways in the yeast Saccharomyces cerevisiae","volume":"62","author":"Davenport","year":"1998","journal-title":"Microbiol Mol Biol Rev"},{"key":"5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Roux","year":"2011","journal-title":"Microbiol Mol Biol Rev"},{"key":"6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2174\/138161213804547187","article-title":"Modulation of sensitivity to antitumor agents by targeting the MAPK survival pathway","volume":"19","author":"Perego","year":"2013","journal-title":"Curr Pharm Des"},{"key":"7","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1517\/14728222.2011.639361","article-title":"The RAS\/RAF\/MEK\/ERK and the PI3K\/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches","volume":"16","author":"Normanno","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ejca.2012.11.019","article-title":"Resistance to BRAF-targeted therapy in melanoma","volume":"49","author":"Flaherty","year":"2013","journal-title":"Eur J Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9343(77)90124-3","article-title":"Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte\/macrophage","volume":"63","author":"Papayannopoulou","year":"1977","journal-title":"Am J Med"},{"key":"10","first-page":"191","article-title":"Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era","volume":"3","author":"Saydam","year":"2013","journal-title":"Am J Blood Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/156800911793743637","article-title":"Current treatment concepts of CML","volume":"11","author":"Muller","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/cncr.11520","article-title":"Chronic myelogenous leukemia: a review and update of therapeutic strategies","volume":"98","author":"Kantarjian","year":"2003","journal-title":"Cancer"},{"key":"13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2008.26","article-title":"Contributions of the Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways to leukemia","volume":"22","author":"McCubrey","year":"2008","journal-title":"Leukemia"},{"key":"14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/BJ20040927","article-title":"Modulation of the p38 MAPK (mitogen-activated protein kinase) pathway through Bcr\/Abl: implications in the cellular response to Ara-C","volume":"387","author":"Sanchez-Prieto","year":"2005","journal-title":"Biochem J"},{"key":"15","doi-asserted-by":"crossref","first-page":"e6124","DOI":"10.1371\/journal.pone.0006124","article-title":"ERK2, but not ERK1, mediates acquired and \u2018de novo' resistance to imatinib mesylate: implication for CML therapy","volume":"4","author":"Sanchez Prieto","year":"2009","journal-title":"PLoS One"},{"key":"16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Filipowicz","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Anderson","year":"2007","journal-title":"Dev Biol"},{"key":"20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semcdb.2004.11.007","article-title":"Mechanisms of translational control by the 3\u2032 UTR in development and differentiation","volume":"16","author":"Lissenden","year":"2005","journal-title":"Semin Cell Dev Biol"},{"key":"21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ng865","article-title":"Micro RNAs are complementary to 3\u2032 UTR sequence motifs that mediate negative post-transcriptional regulation","volume":"30","author":"Lai","year":"2002","journal-title":"Nat Genet"},{"key":"22","doi-asserted-by":"crossref","first-page":"15557","DOI":"10.1073\/pnas.0507443102","article-title":"Human microRNAs target a functionally distinct population of genes with AT-rich 3\u2032 UTRs","volume":"102","author":"Press","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.cell.2005.11.023","article-title":"Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3\u2032UTR evolution","volume":"123","author":"Cohen","year":"2005","journal-title":"Cell"},{"key":"24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Ambros","year":"1993","journal-title":"Cell"},{"key":"25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11010-013-1958-2","article-title":"Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemia","volume":"390","author":"Liu","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/blood.V81.1.158.158","article-title":"The ABL-BCR fusion gene is expressed in chronic myeloid leukemia","volume":"81","author":"Goldman","year":"1993","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/sj.leu.2402577","article-title":"Chronic myelogenous leukemia: mechanisms underlying disease progression","volume":"16","author":"Verfaillie","year":"2002","journal-title":"Leukemia"},{"key":"28","first-page":"103","article-title":"A minute chromosome in human chronic granulocytic leukemia","volume":"132","author":"Hungerford","year":"2004","journal-title":"Landmarks in Medical Genetics: Classic Papers with Commentaries"},{"key":"29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"30","first-page":"1497","article-title":"The Philadelphia Chromosome","volume":"132","author":"Lynch","year":"1960","journal-title":"Science"},{"key":"31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/1947601913507951","article-title":"Role of p38 MAP Kinase Signal Transduction in Solid Tumors","volume":"4","author":"Koul","year":"2013","journal-title":"Genes Cancer"},{"key":"32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Choi","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1349-7006.2006.00244.x","article-title":"ERK MAP kinase in G cell cycle progression and cancer","volume":"97","author":"Nishida","year":"2006","journal-title":"Cancer Sci"},{"key":"34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-8674(05)80094-7","article-title":"BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein","volume":"75","author":"Gishizky","year":"1993","journal-title":"Cell"},{"key":"35","doi-asserted-by":"crossref","first-page":"22925","DOI":"10.1016\/S0021-9258(17)31596-X","article-title":"Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia","volume":"269","author":"Druker","year":"1994","journal-title":"J Biol Chem"},{"key":"36","first-page":"899","article-title":"Constitutive phosphorylation of Shc proteins in human tumors","volume":"11","author":"Pelicci","year":"1995","journal-title":"Oncogene"},{"key":"37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0960-9822(02)00410-4","article-title":"Signalling pathways: jack of all cascades","volume":"6","author":"Nordheim","year":"1996","journal-title":"Curr Biol"},{"key":"38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.14202\/vetworld.2013.761-765","article-title":"MicroRNA: biogenesis and computational target identification: a review","volume":"6","author":"Panigrahi","year":"2013","journal-title":"Veterinary World"},{"key":"39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-10-41","article-title":"Expression patterns of microRNAs associated with CML phases and their disease related targets","volume":"10","author":"Moravcov\u00e1","year":"2011","journal-title":"Molecular cancer"},{"key":"40","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia\u2014advances in biology and new approaches to treatment","volume":"349","author":"Melo","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"41","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1038\/sj.onc.1206082","article-title":"BCR\/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia","volume":"21","author":"Verfaillie","year":"2002","journal-title":"Oncogene"},{"key":"42","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Baltimore","year":"1990","journal-title":"Science"},{"key":"43","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1073\/pnas.85.23.9312","article-title":"Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr\/abl protein","volume":"85","author":"Baltimore","year":"1988","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"44","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1073\/pnas.90.8.3755","article-title":"Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice","volume":"90","author":"Witte","year":"1993","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"45","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Melo","year":"2000","journal-title":"Blood"},{"key":"46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccr.2008.04.018","article-title":"Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression","volume":"13","author":"Malumbres","year":"2008","journal-title":"Cancer cell"},{"key":"47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13000-015-0255-7","article-title":"miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2","volume":"10","author":"Da","year":"2015","journal-title":"Diagnostic pathology"},{"key":"48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature06642","article-title":"A skin microRNA promotes differentiation by repressing \u2018stemness'","volume":"452","author":"Fuchs","year":"2008","journal-title":"Nature"},{"key":"49","doi-asserted-by":"crossref","first-page":"e61858","DOI":"10.1371\/journal.pone.0061858","article-title":"Inhibition of BCR\/ABL protein expression by miR-203 sensitizes for imatinib mesylate","volume":"8","author":"Feng","year":"2013","journal-title":"PLoS One"},{"key":"50","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.leukres.2013.07.019","article-title":"Imatinib induces demethylation of miR-203 gene: An epigenetic mechanism of anti-tumor effect of imatinib","volume":"37","author":"Umemura","year":"2013","journal-title":"Leukemia research"},{"key":"51","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1111\/j.1582-4934.2011.01274.x","article-title":"Epigenetic inactivation of the hsa-miR-203 in haematological malignancies","volume":"15","author":"Yu","year":"2011","journal-title":"Journal of cellular and molecular medicine"},{"key":"52","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood-2014-06-581926","article-title":"MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors","volume":"125","author":"Sun","year":"2015","journal-title":"Blood"},{"key":"53","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1126\/science.1097434","article-title":"MicroRNA-directed cleavage of HOXB8 mRNA","volume":"304","author":"Bartel","year":"2004","journal-title":"Science"},{"key":"54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1582-4934.2010.01219.x","article-title":"MicroRNA-196: critical roles and clinical applications in development and cancer","volume":"15","author":"Yao","year":"2011","journal-title":"Journal of cellular and molecular medicine"},{"key":"55","doi-asserted-by":"crossref","first-page":"e68442","DOI":"10.1371\/journal.pone.0068442","article-title":"Low expression of miR-196b enhances the expression of BCR-ABL1 and HOXA9 oncogenes in chronic myeloid leukemogenesis","volume":"8","author":"Yin","year":"2013","journal-title":"PloS one"},{"key":"56","doi-asserted-by":"crossref","first-page":"e9219","DOI":"10.1371\/journal.pone.0009219","article-title":"Overexpression of microRNA miR-30a or miR-191 in A549 lung cancer or BEAS-2B normal lung cell lines does not alter phenotype","volume":"5","author":"Yendamuri","year":"2010","journal-title":"PloS one"},{"key":"57","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/ijc.27981","article-title":"Meta-analysis of microRNA expression in lung cancer","volume":"132","author":"Annilo","year":"2013","journal-title":"International Journal of Cancer"},{"key":"58","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"miR-133 and miR-30 regulate connective tissue growth factor Implications for a role of microRNAs in myocardial matrix remodeling","volume":"104","author":"Barenbrug","year":"2009","journal-title":"Circulation research"},{"key":"59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.leukres.2012.12.003","article-title":"Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemia","volume":"37","author":"Yin","year":"2013","journal-title":"Leukemia research"},{"key":"60","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/leu.2012.65","article-title":"Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells","volume":"26","author":"Cao","year":"2012","journal-title":"Leukemia"},{"key":"61","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3892\/or.2014.3036","article-title":"Diverse roles of miR-29 in cancer (Review)","volume":"31","author":"Jiang","year":"2014","journal-title":"Oncology reports"},{"key":"62","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/CIRCRESAHA.111.256388","article-title":"Modulating the MicroRNArchitecture of an aging aorta","volume":"109","author":"Olson","year":"2011","journal-title":"Circulation research"},{"key":"63","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1152\/physiolgenomics.00141.2011","article-title":"The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury","volume":"44","author":"Liang","year":"2012","journal-title":"Physiological genomics"},{"key":"64","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.bjc.6605751","article-title":"The tumour-suppressive miR-29a\/b1 cluster is regulated by CEBPA and blocked in human AML","volume":"103","author":"Pabst","year":"2010","journal-title":"British journal of cancer"},{"key":"65","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.yexcr.2013.02.002","article-title":"miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR\/ABL1 protein","volume":"319","author":"Feng","year":"2013","journal-title":"Exp Cell Res"},{"key":"66","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.leu.2403999","article-title":"Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation","volume":"20","author":"Bonnet","year":"2006","journal-title":"Leukemia"},{"key":"67","first-page":"296139","article-title":"Upregulated microRNA-155 expression in peripheral blood mononuclear cells and fibroblast-like synoviocytes in rheumatoid arthritis","volume":"2013","author":"Li","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1089\/jir.2012.0062","article-title":"Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia","volume":"33","author":"Hassel","year":"2013","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1476-4598-8-69","article-title":"MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations","volume":"8","author":"Pr\u00f3sper","year":"2009","journal-title":"Mol Cancer"},{"key":"70","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.yexcr.2013.02.002","article-title":"miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR\/ABL1 protein","volume":"319","author":"Feng","year":"2013","journal-title":"Experimental cell research"},{"key":"71","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5507\/bp.2014.029","article-title":"The role of miR-29 family members in malignant hematopoiesis","volume":"158","author":"Modriansky","year":"2014","journal-title":"Biomedical Papers"},{"key":"72","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Tuschl","year":"2002","journal-title":"Current Biology"},{"key":"73","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1261\/rna.2322506","article-title":"Post-transcriptional regulation of microRNA expression","volume":"12","author":"Martinez","year":"2006","journal-title":"RNA"},{"key":"74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2009.05.030","article-title":"MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines","volume":"286","author":"Zhou","year":"2009","journal-title":"Cancer letters"},{"key":"75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/onc.2012.557","article-title":"BCR-ABL\/GATA1\/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia","volume":"33","author":"Luo","year":"2014","journal-title":"Oncogene"},{"key":"76","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/332272a0","article-title":"A novel viral oncogene with structural similarity to phospholipase C","volume":"332","author":"Hanafusa","year":"1988","journal-title":"Nature"},{"key":"77","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/sj.onc.1206714","article-title":"CrkIII: a novel and biologically distinct member of the Crk family of adaptor proteins","volume":"22","author":"Sorokin","year":"2003","journal-title":"Oncogene"},{"key":"78","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1128\/MCB.12.8.3482","article-title":"Two species of human CRK cDNA encode proteins with distinct biological activities","volume":"12","author":"Shibuya","year":"1992","journal-title":"Molecular and Cellular Biology"},{"key":"79","first-page":"1469","article-title":"Tyrosine phosphorylation of murine Crkl","volume":"11","author":"Groffen","year":"1995","journal-title":"Oncogene"},{"key":"80","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/1947601912459951","article-title":"Models of crk adaptor proteins in cancer","volume":"3","author":"Park","year":"2012","journal-title":"Genes Cancer"},{"key":"81","first-page":"2469","article-title":"Isolation and chromosomal localization of CRKL, a human crk-like gene","volume":"8","author":"Groffen","year":"1993","journal-title":"Oncogene"},{"key":"82","doi-asserted-by":"crossref","first-page":"22925","DOI":"10.1016\/S0021-9258(17)31596-X","article-title":"Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia","volume":"269","author":"Druker","year":"1994","journal-title":"Journal of Biological Chemistry"},{"key":"83","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood.V84.9.2912.2912","article-title":"Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells","volume":"84","author":"Golde","year":"1994","journal-title":"Blood"},{"key":"84","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1128\/MCB.14.8.5495","article-title":"CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells","volume":"14","author":"Hattori","year":"1994","journal-title":"Molecular and Cellular Biology"},{"key":"85","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1100\/tsw.2010.198","article-title":"miR-126 and miR-126*: new players in cancer","volume":"10","author":"Schmidt","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"86","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","article-title":"Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters","volume":"132","author":"Jacks","year":"2008","journal-title":"Cell"},{"key":"87","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","article-title":"The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis","volume":"15","author":"Olson","year":"2008","journal-title":"Dev Cell"},{"key":"88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-10-41","article-title":"Expression patterns of microRNAs associated with CML phases and their disease related targets","volume":"10","author":"Moravcova","year":"2011","journal-title":"Mol Cancer"},{"key":"89","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3892\/ijo_00000570","article-title":"miR-221\/222 promote malignant progression of glioma through activation of the Akt pathway","volume":"36","author":"Kang","year":"2010","journal-title":"Int J Oncol"},{"key":"90","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1080372","article-title":"Vertebrate microRNA genes","volume":"299","author":"Bartel","year":"2003","journal-title":"Science"},{"key":"91","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbrc.2004.07.130","article-title":"Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells","volume":"322","author":"Kozu","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"92","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1476-4598-9-229","article-title":"MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma","volume":"9","author":"Kang","year":"2010","journal-title":"Mol Cancer"},{"key":"93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.gpb.2014.02.001","article-title":"Characterization of miRNomes in acute and chronic myeloid leukemia cell lines","volume":"12","author":"Fang","year":"2014","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"94","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1261\/rna.2146903","article-title":"New microRNAs from mouse and human","volume":"9","author":"Tuschl","year":"2003","journal-title":"RNA"},{"key":"95","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1745-6150-6-23","article-title":"MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival","volume":"6","author":"Lawrie","year":"2011","journal-title":"Biol Direct"},{"key":"96","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Tuschl","year":"2002","journal-title":"Curr Biol"},{"key":"97","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","article-title":"Identification of novel genes coding for small expressed RNAs","volume":"294","author":"Tuschl","year":"2001","journal-title":"Science"},{"key":"98","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Croce","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"99","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1158\/1541-7786.MCR-08-0167","article-title":"Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth","volume":"6","author":"Fortes","year":"2008","journal-title":"Mol Cancer Res"},{"key":"100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0092-8674(93)90169-Q","article-title":"An SH3-SH2-SH3 protein is required for p21Ras1 activation and binds to sevenless and Sos proteins","volume":"73","author":"Rubin","year":"1993","journal-title":"Cell"},{"key":"101","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0092-8674(91)90207-F","article-title":"Genetic dissection of a neurodevelopmental pathway: Son of sevenless functions downstream of the sevenless and EGF receptor tyrosine kinases","volume":"64","author":"Banerjee","year":"1991","journal-title":"Cell"},{"key":"102","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1478-811X-7-13","article-title":"Crk and CrkL adaptor proteins: networks for physiological and pathological signaling","volume":"7","author":"Tanaka","year":"2009","journal-title":"Cell Commun Signal"},{"key":"103","doi-asserted-by":"crossref","first-page":"e35501","DOI":"10.1371\/journal.pone.0035501","article-title":"Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells","volume":"7","author":"Shpilberg","year":"2012","journal-title":"PLoS One"},{"key":"104","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/08830180903093796","article-title":"miR-155: on the crosstalk between inflammation and cancer","volume":"28","author":"Michaille","year":"2009","journal-title":"Int Rev Immunol"},{"key":"105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2043-9113-3-17","article-title":"The multiple roles of microRNA-155 in oncogenesis","volume":"3","author":"Slack","year":"2013","journal-title":"J Clin Bioinforma"},{"key":"106","doi-asserted-by":"crossref","first-page":"e32834","DOI":"10.1371\/journal.pone.0032834","article-title":"miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML)","volume":"7","author":"Luo","year":"2012","journal-title":"PLoS One"},{"key":"107","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1158\/0008-5472.CAN-06-0561","article-title":"Patterns of known and novel small RNAs in human cervical cancer","volume":"67","author":"Fire","year":"2007","journal-title":"Cancer Res"},{"key":"108","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microRNA expression atlas based on small RNA library sequencing","volume":"129","author":"Foa","year":"2007","journal-title":"Cell"},{"key":"109","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ng1590","article-title":"Identification of hundreds of conserved and nonconserved human microRNAs","volume":"37","author":"Bentwich","year":"2005","journal-title":"Nat Genet"},{"key":"110","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/leu.2008.382","article-title":"The role of microRNA in human leukemia: a review","volume":"23","author":"Calin","year":"2009","journal-title":"Leukemia"},{"key":"111","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrm1105","article-title":"Ras proteins: different signals from different locations","volume":"4","author":"Hancock","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"112","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/348125a0","article-title":"The GTPase superfamily: a conserved switch for diverse cell functions","volume":"348","author":"McCormick","year":"1990","journal-title":"Nature"},{"key":"113","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1128\/MCB.7.6.2128","article-title":"Guanine nucleotide activation of, and competition between, RAS proteins from Saccharomyces cerevisiae","volume":"7","author":"Wigler","year":"1987","journal-title":"Mol Cell Biol"},{"key":"114","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1128\/MCB.7.12.4553","article-title":"Induction of neurite formation in PC12 cells by microinjection of proto-oncogenic Ha-ras protein preincubated with guanosine-5\u2032-O-(3-thiotriphosphate)","volume":"7","author":"Kaziro","year":"1987","journal-title":"Mol Cell Biol"},{"key":"115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0968-0004(91)90156-P","article-title":"The structure of Ras protein: a model for a universal molecular switch","volume":"16","author":"Pai","year":"1991","journal-title":"Trends Biochem Sci"},{"key":"116","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1126\/science.2181667","article-title":"A cytosolic protein catalyzes the release of GDP from p21ras","volume":"248","author":"Macara","year":"1990","journal-title":"Science"},{"key":"117","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1126\/science.2821624","article-title":"A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants","volume":"238","author":"McCormick","year":"1987","journal-title":"Science"},{"key":"118","doi-asserted-by":"crossref","first-page":"24052","DOI":"10.1074\/jbc.273.37.24052","article-title":"Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase","volume":"273","author":"Hancock","year":"1998","journal-title":"J Biol Chem"},{"key":"119","doi-asserted-by":"crossref","first-page":"15609","DOI":"10.1074\/jbc.M010573200","article-title":"Differential activation of the Rac pathway by Ha-Ras and K-Ras","volume":"276","author":"Bar-Sagi","year":"2001","journal-title":"J Biol Chem"},{"key":"120","doi-asserted-by":"crossref","first-page":"19315","DOI":"10.1074\/jbc.M000250200","article-title":"Endogenous c-N-Ras provides a steady-state anti-apoptotic signal","volume":"275","author":"Wolfman","year":"2000","journal-title":"J Biol Chem"},{"key":"121","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/sj.onc.1201653","article-title":"Ha-ras and N-ras regulate MAPK activity by distinct mechanisms","volume":"16","author":"Wolfman","year":"1998","journal-title":"Oncogene"},{"key":"122","first-page":"4682","article-title":"ras oncogenes in human cancer: a review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Res"},{"key":"123","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/364352a0","article-title":"Direct interaction of Ras and the amino-terminal region of Raf-1","volume":"364","author":"Downward","year":"1993","journal-title":"Nature"},{"key":"124","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0092-8674(93)90307-C","article-title":"Mammalian Ras interacts directly with the serine\/threonine kinase Raf","volume":"74","author":"Cooper","year":"1993","journal-title":"Cell"},{"key":"125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/364308a0","article-title":"Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1","volume":"364","author":"Avruch","year":"1993","journal-title":"Nature"},{"key":"126","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1126\/science.8503013","article-title":"Complexes of Ras. GTP with Raf-1 and mitogen-activated protein kinase kinase","volume":"260","author":"Wolfman","year":"1993","journal-title":"Science"},{"key":"127","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1423-0127-20-79","article-title":"MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1","volume":"20","author":"Deng","year":"2013","journal-title":"J Biomed Sci"},{"key":"128","first-page":"935","article-title":"Extracellular chromosome 21-derived microRNAs in euploid & aneuploid pregnancies","volume":"138","author":"Hromadnikova","year":"2013","journal-title":"Indian J Med Res"},{"key":"129","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1182\/blood-2010-05-285064","article-title":"MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia","volume":"117","author":"Trneny","year":"2011","journal-title":"Blood"},{"key":"130","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/nm.2459","article-title":"Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155","volume":"17","author":"Byers","year":"2011","journal-title":"Nat Med"},{"key":"131","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-1119(01)00612-6","article-title":"Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA","volume":"274","author":"Tam","year":"2001","journal-title":"Gene"},{"key":"132","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/BJ20130833","article-title":"The miR-19a\/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1","volume":"457","author":"Kim do","year":"2014","journal-title":"Biochem J"},{"key":"133","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1101\/gad.1861409","article-title":"miR-19 is a key oncogenic component of miR-17-92","volume":"23","author":"He","year":"2009","journal-title":"Genes Dev"},{"key":"134","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1182\/blood-2006-09-045104","article-title":"Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells","volume":"109","author":"Scherr","year":"2007","journal-title":"Blood"},{"key":"135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.6691137","article-title":"The human homologs of the raf (mil) oncogene are located on human chromosomes 3 and 4","volume":"223","author":"Leder","year":"1984","journal-title":"Science"},{"key":"136","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Der","year":"2007","journal-title":"Oncogene"},{"key":"137","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1073\/pnas.83.11.3934","article-title":"Actively transcribed genes in the raf oncogene group, located on the X chromosome in mouse and human","volume":"83","author":"Rapp","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"138","first-page":"4","article-title":"MAP kinase pathways","author":"Morrison","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"139","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm2438","article-title":"Ras oncogenes: split personalities","volume":"9","author":"Weinberg","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"140","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/cdd.2013.125","article-title":"The miR-17-92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease","volume":"20","author":"Rigoutsos","year":"2013","journal-title":"Cell Death Differ"},{"key":"141","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1582-4934.2008.00386.x","article-title":"The microRNAs involved in human myeloid differentiation and myelogenous\/myeloblastic leukemia","volume":"12","author":"Zhang","year":"2008","journal-title":"J Cell Mol Med"},{"key":"142","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2003-04-1271","article-title":"BCR\/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells","volume":"103","author":"Bhatia","year":"2004","journal-title":"Blood"},{"key":"143","first-page":"D165","article-title":"miRNAMap 2. 0: genomic maps of microRNAs in metazoan genomes","volume":"36","author":"Huang","year":"2008","journal-title":"Nucleic Acids Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:44:37Z","timestamp":1655253877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":143,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2106,7,5]]}},"alternative-id":["7977","26967056"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7977","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]}}}